Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Exposure-safety and exposure-efficacy analyses for tisotumab vedotin for patients with locally advanced or metastatic solid tumors.
Passey C, Voellinger J, Gibiansky L, Gunawan R, Nicacio L, Soumaoro I, Hanley WD, Winter H, Gupta M. Passey C, et al. Among authors: voellinger j. CPT Pharmacometrics Syst Pharmacol. 2023 Sep;12(9):1262-1273. doi: 10.1002/psp4.13007. Epub 2023 Jul 26. CPT Pharmacometrics Syst Pharmacol. 2023. PMID: 37496366 Free PMC article.
Identification of an N-terminal tag (580N) that improves the biosynthesis of fluorescent proteins in Francisella tularensis and other Gram-negative bacteria.
Haggerty K, Cantlay S, Young E, Cashbaugh MK, Delatore Iii EF, Schreiber R, Hess H, Komlosi DR, Butler S, Bolon D, Evangelista T, Hager T, Kelly C, Phillips K, Voellinger J, Shanks RMQ, Horzempa J. Haggerty K, et al. Among authors: voellinger j. Mol Cell Probes. 2024 Apr;74:101956. doi: 10.1016/j.mcp.2024.101956. Epub 2024 Mar 19. Mol Cell Probes. 2024. PMID: 38492609 Free PMC article.
A phase 1 trial of vadastuximab talirine combined with hypomethylating agents in patients with CD33-positive AML.
Fathi AT, Erba HP, Lancet JE, Stein EM, Ravandi F, Faderl S, Walter RB, Advani AS, DeAngelo DJ, Kovacsovics TJ, Jillella A, Bixby D, Levy MY, O'Meara MM, Ho PA, Voellinger J, Stein AS. Fathi AT, et al. Among authors: voellinger j. Blood. 2018 Sep 13;132(11):1125-1133. doi: 10.1182/blood-2018-03-841171. Epub 2018 Jul 25. Blood. 2018. PMID: 30045838 Free PMC article. Clinical Trial.
Development of a microphysiological model of human kidney proximal tubule function.
Weber EJ, Chapron A, Chapron BD, Voellinger JL, Lidberg KA, Yeung CK, Wang Z, Yamaura Y, Hailey DW, Neumann T, Shen DD, Thummel KE, Muczynski KA, Himmelfarb J, Kelly EJ. Weber EJ, et al. Among authors: voellinger jl. Kidney Int. 2016 Sep;90(3):627-37. doi: 10.1016/j.kint.2016.06.011. Kidney Int. 2016. PMID: 27521113 Free PMC article.
Identification of CYP3A7 for glyburide metabolism in human fetal livers.
Shuster DL, Risler LJ, Prasad B, Calamia JC, Voellinger JL, Kelly EJ, Unadkat JD, Hebert MF, Shen DD, Thummel KE, Mao Q. Shuster DL, et al. Among authors: voellinger jl. Biochem Pharmacol. 2014 Dec 15;92(4):690-700. doi: 10.1016/j.bcp.2014.09.025. Epub 2014 Oct 22. Biochem Pharmacol. 2014. PMID: 25450675 Free PMC article.
Innovations in preclinical biology: ex vivo engineering of a human kidney tissue microperfusion system.
Kelly EJ, Wang Z, Voellinger JL, Yeung CK, Shen DD, Thummel KE, Zheng Y, Ligresti G, Eaton DL, Muczynski KA, Duffield JS, Neumann T, Tourovskaia A, Fauver M, Kramer G, Asp E, Himmelfarb J. Kelly EJ, et al. Among authors: voellinger jl. Stem Cell Res Ther. 2013;4 Suppl 1(Suppl 1):S17. doi: 10.1186/scrt378. Epub 2013 Dec 20. Stem Cell Res Ther. 2013. PMID: 24564863 Free PMC article. Review.